María del Pilar
Herrera Puente
Profesor/a Asociado/a en CC. de la Salud
Hospital Duran i Reynals
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Duran i Reynals (5)
2024
-
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial
Haematologica, Vol. 109, Núm. 2, pp. 543-552
2022
-
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC
Transplantation and Cellular Therapy, Vol. 28, Núm. 4, pp. 204.e1-204.e10
2021
-
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain
Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 10, pp. e801-e809
2017
-
Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML
Bone Marrow Transplantation, Vol. 52, Núm. 8, pp. 1138-1143
2010
-
Histología y biomarcadores en la enfermedad del injerto contra el huésped cutánea
Methods and Findings in Experimental and Clinical Pharmacology, Vol. 32, Núm. SUPPL. A, pp. 19-23